Valuation: Pathkey.AI Ltd

Market Cap 41.28M 28.41M 24.87M 22.96M 21.44M 40.36M 2.69B 276M 107M 1.32B 107M 104M 4.6B P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 41.26M 28.39M 24.86M 22.95M 21.43M 40.34M 2.68B 276M 107M 1.32B 107M 104M 4.6B EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
1 day+4.62%
1 week+33.33%
Current month+65.85%
1 month+74.36%
3 months+183.33%
6 months+325.00%
Current year+325.00%
1 week 0.05
Extreme 0.051
0.08
1 month 0.04
Extreme 0.037
0.08
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.23
10 years 0.01
Extreme 0.014
3.4
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 16/01/1994
Chief Executive Officer - 10/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 20/10/2025
Director/Board Member - 20/10/2025
Chairman - 25/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
+4.62%+33.33%+134.48%+209.09% 27.15M
-0.92%+9.21%-39.43%-11.79% 28.63B
+3.03%+17.64%-28.64%+209.92% 14.19B
+0.07%-2.77%-21.97%+51.13% 5.4B
-12.28%-11.54% - - 3.01B
-2.78%+6.42% - - 2.17B
-0.92%+5.21%+37.45%-45.15% 1.86B
+1.95%+5.71%-17.56% - 1.3B
+1.49%+5.31%-34.87%+244.71% 758M
+2.23%-6.69%-43.59%-61.37% 731M
Average -0.35%+4.76%-1.77%+85.22% 5.81B
Weighted average by Cap. -0.43%+11.14%-31.41%+57.77%

Financials

2024 2025
Net sales 398K 274K 240K 221K 207K 389K 25.87M 2.66M 1.03M 12.76M 1.03M 1M 44.31M 322K 222K 194K 179K 167K 315K 20.95M 2.16M 832K 10.33M 832K 814K 35.88M
Net income -3.13M -2.15M -1.89M -1.74M -1.63M -3.06M -204M -20.95M -8.09M -100M -8.09M -7.91M -349M -1.45M -996K -872K -805K -752K -1.42M -94.18M -9.69M -3.74M -46.46M -3.74M -3.66M -161M
Net Debt -375K -258K -226K -208K -195K -366K -24.37M -2.51M -968K -12.02M -968K -947K -41.75M -25.17K -17.32K -15.16K -14K -13.07K -24.61K -1.64M -168K -65.03K -808K -65.03K -63.6K -2.8M
Logo Pathkey.AI Ltd
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
30/06/26 A$0.0680 +4.62% 4,360,629
29/06/26 A$0.0650 -8.45% 16,541,655
26/06/26 A$0.0710 +18.33% 13,657,718
25/06/26 A$0.0600 +7.14% 4,617,873
24/06/26 A$0.0560 +9.80% 16,454,071